Envoy Medical Stock Analysis

COCH Stock   2.67  0.13  4.64%   
Envoy Medical is undervalued with Real Value of 3.15 and Target Price of 4.0. The main objective of Envoy Medical stock analysis is to determine its intrinsic value, which is an estimate of what Envoy Medical is worth, separate from its market price. There are two main types of Envoy Medical's stock analysis: fundamental analysis and technical analysis.
The Envoy Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Envoy Medical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Envoy Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more detail on how to invest in Envoy Stock please use our How to Invest in Envoy Medical guide.

Envoy Stock Analysis Notes

About 64.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.83. Envoy Medical had not issued any dividends in recent years. For more info on Envoy Medical please contact Brent Esq at 877 900 3277 or go to https://www.envoymedical.com.

Envoy Medical Quarterly Total Revenue

68,000

Envoy Medical Investment Alerts

Envoy Medical had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 316 K. Net Loss for the year was (29.91 M) with loss before overhead, payroll, taxes, and interest of (720 K).
Envoy Medical generates negative cash flow from operations
Envoy Medical has a frail financial position based on the latest SEC disclosures
About 64.0% of the company shares are held by company insiders
Latest headline from MacroaxisInsider: Discretionary transaction by Barclays Plc of 333019 shares of Envoy Medical at 11.5 subject to Rule 16b-3

Envoy Medical Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Envoy Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
16th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View
16th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Envoy Largest EPS Surprises

Earnings surprises can significantly impact Envoy Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-15
2024-03-31-0.26-0.32-0.0623 
2023-12-31
2023-12-31-0.19-0.39-0.2105 
View All Earnings Estimates

Envoy Medical Environmental, Social, and Governance (ESG) Scores

Envoy Medical's ESG score is a quantitative measure that evaluates Envoy Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Envoy Medical's operations that may have significant financial implications and affect Envoy Medical's stock price as well as guide investors towards more socially responsible investments.

Envoy Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 52.68 M.

Envoy Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(3.91)(4.11)
Return On Capital Employed(18.30)(19.21)
Return On Assets(3.91)(4.11)
Return On Equity 16.97  17.82 

Management Efficiency

Envoy Medical has return on total asset (ROA) of (2.6632) % which means that it has lost $2.6632 on every $100 spent on assets. This is way below average. Envoy Medical's management efficiency ratios could be used to measure how well Envoy Medical manages its routine affairs as well as how well it operates its assets and liabilities. The Envoy Medical's current Return On Equity is estimated to increase to 17.82, while Return On Tangible Assets are projected to decrease to (4.11). As of now, Envoy Medical's Total Assets are increasing as compared to previous years. The Envoy Medical's current Total Current Assets is estimated to increase to about 7.2 M, while Non Current Assets Total are projected to decrease to under 551.6 K.
Last ReportedProjected for Next Year
Book Value Per Share(0.14)(0.15)
Tangible Book Value Per Share(0.14)(0.15)
Enterprise Value Over EBITDA(1.04)(1.09)
Price Book Value Ratio(12.90)(12.25)
Enterprise Value Multiple(1.04)(1.09)
Price Fair Value(12.90)(12.25)
Enterprise Value18.9 M18 M
The analysis of Envoy Medical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Envoy Medical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Envoy Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Operating Margin
(71.47)
Beta
2.32
Return On Assets
(2.66)

Technical Drivers

As of the 13th of October 2024, Envoy Medical shows the Downside Deviation of 6.5, mean deviation of 4.97, and Coefficient Of Variation of 1520.12. Envoy Medical technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Envoy Medical Price Movement Analysis

Execute Study
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Envoy Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Envoy Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Envoy Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Envoy Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Envoy Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Envoy Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Barclays Plc a day ago
Discretionary transaction by Barclays Plc of 333019 shares of Envoy Medical at 11.5 subject to Rule 16b-3
 
Barclays Plc 2 days ago
Discretionary transaction by Barclays Plc of 333019 shares of Envoy Medical at 11.5 subject to Rule 16b-3
 
Barclays Plc 3 days ago
Discretionary transaction by Barclays Plc of 333019 shares of Envoy Medical at 11.5 subject to Rule 16b-3
 
Barclays Plc few days ago
Discretionary transaction by Barclays Plc of 333019 shares of Envoy Medical at 11.5 subject to Rule 16b-3
 
Barclays Plc few days ago
Discretionary transaction by Barclays Plc of 333019 shares of Envoy Medical at 11.5 subject to Rule 16b-3
 
Barclays Plc few days ago
Discretionary transaction by Barclays Plc of 333019 shares of Envoy Medical at 11.5 subject to Rule 16b-3
 
Barclays Plc six days ago
Discretionary transaction by Barclays Plc of 333019 shares of Envoy Medical at 11.5 subject to Rule 16b-3
 
Barclays Plc over a week ago
Discretionary transaction by Barclays Plc of 333019 shares of Envoy Medical at 11.5 subject to Rule 16b-3
 
Barclays Plc over a week ago
Discretionary transaction by Barclays Plc of 333019 shares of Envoy Medical at 11.5 subject to Rule 16b-3
 
Barclays Plc over a week ago
Discretionary transaction by Barclays Plc of 333019 shares of Envoy Medical at 11.5 subject to Rule 16b-3
 
Barclays Plc over a week ago
Discretionary transaction by Barclays Plc of 333019 shares of Envoy Medical at 11.5 subject to Rule 16b-3
 
Barclays Plc over a week ago
Discretionary transaction by Barclays Plc of 333019 shares of Envoy Medical at 11.5 subject to Rule 16b-3

Envoy Medical Predictive Daily Indicators

Envoy Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Envoy Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Envoy Medical Corporate Filings

4th of October 2024
Other Reports
ViewVerify
3rd of October 2024
Other Reports
ViewVerify
F4
11th of September 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
6th of September 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
29th of August 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
28th of August 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
10Q
12th of August 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
8K
1st of August 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Envoy Medical Forecast Models

Envoy Medical's time-series forecasting models are one of many Envoy Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Envoy Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Envoy Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Envoy Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Envoy shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Envoy Medical. By using and applying Envoy Stock analysis, traders can create a robust methodology for identifying Envoy entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(94.65)(99.38)
Operating Profit Margin(58.14)(61.04)
Net Loss(94.65)(99.38)
Gross Profit Margin(1.50)(1.57)

Current Envoy Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Envoy analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Envoy analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
4.0Strong Buy3Odds
Envoy Medical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Envoy analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Envoy stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Envoy Medical, talking to its executives and customers, or listening to Envoy conference calls.
Envoy Analyst Advice Details

Envoy Stock Analysis Indicators

Envoy Medical stock analysis indicators help investors evaluate how Envoy Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Envoy Medical shares will generate the highest return on investment. By understating and applying Envoy Medical stock analysis, traders can identify Envoy Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow183 K
Common Stock Shares Outstanding12.6 M
Total Stockholder Equity-1.8 M
Property Plant And Equipment Net815 K
Cash And Short Term Investments4.2 M
Cash4.2 M
Accounts Payable1.6 M
Net Debt-3.8 M
50 Day M A2.9725
Total Current Liabilities6.6 M
Other Operating Expenses30.2 M
Non Current Assets Total815 K
Non Currrent Assets Other-1.00
Stock Based Compensation1.6 M

Complementary Tools for Envoy Stock analysis

When running Envoy Medical's price analysis, check to measure Envoy Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Envoy Medical is operating at the current time. Most of Envoy Medical's value examination focuses on studying past and present price action to predict the probability of Envoy Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Envoy Medical's price. Additionally, you may evaluate how the addition of Envoy Medical to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments